Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

patient safety

This page shows the latest patient safety news and features for those working in and with pharma, biotech and healthcare.

MHRA to introduce new UK clinical trials framework

MHRA to introduce new UK clinical trials framework

important changes to UK clinical trials regulation centred on patient safety and the benefits of participating in research.

Latest news

More from news
Approximately 71 fully matching, plus 258 partially matching documents found.

Latest Intelligence

  • Rare diseases: not so rare after all Rare diseases: not so rare after all

    issues. Greater patient involvement, leading to improved approaches for patient assessment of drug efficacy and safety. ... ERT provides the patient with the recombinantly produced missing enzyme and is now widely available for several LSDs.

  • Merging global and local pharmacovigilance operations into a successful integrated approach Merging global and local pharmacovigilance operations into a successful integrated approach

    An integrated approach to global and local PV and MI is needed to streamline operations and ensure a comprehensive view of information to enhance patient safety overall. ... As AEs are sent to central case processing more quickly, firms can uncover

  • Unlocking the potential of data sharing Unlocking the potential of data sharing

    From early-stage clinical research to screening, diagnosis and patient monitoring and innovative collation and interpretation of data, the sharing of such data is key. ... assessments. With the advent of increasingly sophisticated ways to process the data

  • Concerns about data security are building a strong case for clinical mobility in EMEA Concerns about data security are building a strong case for clinical mobility in EMEA

    However, if we’re compromising patient privacy and safety – or staff privacy and safety, for that matter – are we really helping anyone? ... Doctors and nurses don’t want to be the reason patient information is stolen.

  • CAR-T cell therapy in oncology CAR-T cell therapy in oncology

    Without a sufficiently flexible and redundant design, changing schedules at any point during collection, manufacturing, shipping and delivery can affect the entire workflow, potentially compromising patient and product safety. ... Clinical safety. In

More from intelligence
Approximately 1 fully matching, plus 50 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Putting prevention at the heart of the future of the NHS Putting prevention at the heart of the future of the NHS

    Doctors are now voting on whether to follow them out of the door, raising serious questions about the impact on patient safety.

  • Can Artificial Intelligence Solve the Healthcare Crisis?

    in the pipeline, and how safety and ethics are integral components for its success. ... In addition, potential treatment decisions and outcomes could be modelled to help select the most effective option for each patient.

  • Demonstrating the value of UX research in pharma and healthcare Demonstrating the value of UX research in pharma and healthcare

    If you’re collaborating with medical teams to ensure all patient needs are met, again user research is crucial to cover off all bases. ... Are jobs on the line, or worse, patient’s safety? When articulated well (we’re not here to blackmail!), the

  • Reflections on the MAPS EMEA 2022 Annual Meeting Reflections on the MAPS EMEA 2022 Annual Meeting

    Medical Affairs teams are doing an exemplary job of incorporating the patient perspective, searching for and acting on insights, and driving innovation. ... The importance of an infinite, growth mindset was highlighted in a second keynote presentation by

  • The future of nanomedicine regulation The future of nanomedicine regulation

    In addition, existing safety data requirements are not always appropriate for the analysis of nanomedicines. ... Greater clarity around nanomedicines in the revised pharmaceutical legislation should not only be regarded as a necessary next step to ensure

More from PMHub
Approximately 2 fully matching, plus 27 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Quick links